(Q34186473)

31 July 2017

title

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis (English)

1 reference

Canadian Scleroderma Research Group (CSRG)

31 July 2017

1 reference

7

object named as

Canadian Scleroderma Research Group (CSRG)

1 reference

31 July 2017

8

Marvin J Fritzler

1 reference

31 July 2017

3

Michael Mahler

1 reference

31 July 2017

Janet Pope

2

1 reference

ORCID Public Data File 2021

author name string

Marie Hudson

1

1 reference

31 July 2017

Solène Tatibouet

4

1 reference

31 July 2017

Russell Steele

5

1 reference

31 July 2017

Murray Baron

6

1 reference

31 July 2017

publication date

6 March 2012

1 reference

Arthritis Research and Therapy

31 July 2017

published in

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

R50

1 reference

Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Autoantibodies to intracellular antigens: generation and pathogenetic role.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Clinical and laboratory aspects of Ro/SSA-52 autoantibodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

The role of microparticles in the pathogenesis of rheumatic diseases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Latest update on the Ro/SS-A autoantibody system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Scleroderma prevalence: demographic variations in a population-based sample

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Cell damage and autoimmunity: a critical appraisal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Update on autoantibodies in systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Incidence and prevalence of systemic sclerosis: a systematic literature review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Autoantibodies in systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Autoantibody profiles in the sera of European patients with myositis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

28 July 2018

1 reference

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study

21 January 2018

1 reference

The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity

21 January 2018

1 reference

Polyautoimmunity and familial autoimmunity in systemic sclerosis

21 January 2018

1 reference

Factors influencing polyautoimmunity in systemic lupus erythematosus.

21 January 2018

1 reference

Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Assessment of disease severity and prognosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446416

A disease severity scale for systemic sclerosis: development and testing

28 October 2018

1 reference

12 December 2020

Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis

1 reference

12 December 2020

Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization

1 reference

12 December 2020

Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma

1 reference

12 December 2020

Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies

1 reference

12 December 2020

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

1 reference

12 December 2020

Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients

1 reference

12 December 2020

Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody

1 reference

12 December 2020

Diagnostic utility of anti-Ro52 detection in systemic autoimmunity

1 reference

12 December 2020

Clinical significance of anti-Ro/SSA-52 kDa antibodies: a retrospective monocentric study

1 reference

12 December 2020

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

1 reference

12 December 2020

Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis

1 reference

12 December 2020

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/5njo2hveb5dl3culg3ggiz56oi

Identifiers

1 reference

30 July 2022

Dimensions Publication ID

1052090456

0 references

Fatcat ID

release_5njo2hveb5dl3culg3ggiz56oi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5njo2hveb5dl3culg3ggiz56oi

30 July 2022

https://api.fatcat.wiki/v0/release/5njo2hveb5dl3culg3ggiz56oi

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/5njo2hveb5dl3culg3ggiz56oi

1 reference

30 July 2022